Association Between J-Point Elevation and Death From Coronary Artery Disease: 15-Year Follow-up of the NIPPON DATA90

Background: An early repolarization pattern, characterized by an elevation of the QRS-ST junction (J-point) on 12-lead electrocardiography (ECG) is associated with cardiac and sudden death. However, little is known about the prognostic significance of J-point elevation for various disease-specific c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation Journal 2013, Vol.77(5), pp.1260-1266
Hauptverfasser: Hisamatsu, Takashi, Ohkubo, Takayoshi, Miura, Katsuyuki, Yamamoto, Takashi, Fujiyoshi, Akira, Miyagawa, Naoko, Kadota, Aya, Takashima, Naoyuki, Nagasawa, Shin-ya, Kita, Yoshikuni, Murakami, Yoshitaka, Okayama, Akira, Horie, Minoru, Okamura, Tomonori, Ueshima, Hirotsugu, for the NIPPON DATA90 Research Group
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: An early repolarization pattern, characterized by an elevation of the QRS-ST junction (J-point) on 12-lead electrocardiography (ECG) is associated with cardiac and sudden death. However, little is known about the prognostic significance of J-point elevation for various disease-specific cardiovascular outcomes, including coronary artery disease (CAD). Methods and Results: To investigate the association between the presence of J-point elevation ≥0.1mV and various disease-specific cardiovascular outcomes, we conducted a 15-year prospective study in a representative general Japanese population of 7,630 individuals (41% men, mean age 52.4 years) who participated in the National Survey of Circulatory Disorders. Cox models were used to estimate the hazard ratios (HRs) adjusted for possible confounding factors. J-point elevation was present in 264 individuals (3.5%) and was associated with an increased risk of cardiac death (adjusted HR, 2.54; 95% confidence interval [CI] 1.40–4.58; P=0.002) and death from CAD (adjusted HR, 4.66; 95% CI 2.30–9.46; P
ISSN:1346-9843
1347-4820
DOI:10.1253/circj.CJ-12-1273